The BIO CEO Conference: Highlights from the Meeting and New Investment Perspectives (Subscribers Only)Friday, February 14, 2014 · 4:28 pm |
|
Athersys: The Coming Year Will Define Its Adult Stem Cell Product MultiStem (ATHX, $1.63)Thursday, February 7, 2013 · 3:07 pm |
|
There are 2 reports on file. |